×
Breaking News apps
Get faster updates
Download the free Breaking News app for faster updates, alerts and live video on iOS, Android, Windows, and more
This page is no longer being updated

Australian Football League

Hawthorn Football Club statement: Jarryd Roughead unavailable to play indefinitely after a recurrence of melanoma - @HawthornFC

1 WHOA!

North Carolina, US

Brother of former Rep. Howard Coble, R-NC, says death came after extended hospitalization after complications from skin cancer treatment - @WRAL

13 WHOA!

Food and Drug Administration

FDA approves first-of-its-kind product for the treatment of melanoma - @US_FDA

24 WHOA!

cancer

Former Australian cricket captain Richie Benaud says he is undergoing radiation therapy for skin cancer - @ABCNews

15 WHOA!

skin cancer

Tanning beds, sun lamps will carry new warnings that they should not be used by anyone under age 18 as the federal government works to reduce rising rates of skin cancer linked to the radiation-emitting devices - @AP

End of alert
18 WHOA!

pharmaceuticals

Study: Viagra may boost risk of melanoma - @NBCNews

15 WHOA!

baseball

Minnesota Twins general manager Terry Ryan announces he is being treated for squamous cell carcinoma skin cancer - @MyFOX9

2 WHOA!

health

US health regulators approve 2 new GlaxoSmithKline drugs for treating advanced melanoma - @Reuters

End of alert
1 WHOA!

cancer

1 in 4 skin cancer survivors skip sunscreen, study shows - @NBCNews

0 WHOA!

United Kingdom

UK cost agency rejects new melanoma pill, says benefits of drug unclear - @Reuters

0 WHOA!

United Kingdom

Pill which doubles length of time patients with advanced skin cancer can survive goes on sale in Britain - @Telegraph

0 WHOA!

cancer

US FDA approves drug developed to treat advanced cases of most common type of skin cancer - @WSJ

1 WHOA!

cancer

FDA to announce new testing laws for sunscreens' effectiveness against rays that pose greatest skin cancer risk

1 WHOA!

cancer

New cancer drug reduces risk of death from advanced melanoma by more than 30 percent in late-stage trial

0 WHOA!